The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.

New research shows that people who develop dementia often begin falling behind on bills years earlier.

© Krisanapong Detraphiphat/Getty Images

People with two copies of the gene variant APOE4 are almost certain to get Alzheimer’s, say researchers, who proposed a framework under which such patients could be diagnosed years before symptoms.

© Vsevolod Zviryk/Science Source